Maria Rita Massaro

About Maria Rita Massaro

Maria Rita Massaro, With an exceptional h-index of 5 and a recent h-index of 4 (since 2020), a distinguished researcher at University of Bedfordshire, specializes in the field of Marketing & Innovazione.

His recent articles reflect a diverse array of research interests and contributions to the field:

Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from …

The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma

Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review

PO-1585 Stereotactic ablative radiotherapy (SABR) for multiple oligometastases: efficacy and safety

PD-0806 Pattern of failure after SBRT for oligometastases: predictive factors for poli-progression

PO-1373 Stereotactic Body Radiotherapy in isolated recurrence of pancreatic cancer after radical surgery

Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)

PO-1364 stereotactic radiotherapy for oligometastatic esophagogastric carcinoma outcome, prognostic factors

Maria Rita Massaro Information

University

Position

___

Citations(all)

82

Citations(since 2020)

62

Cited By

33

hIndex(all)

5

hIndex(since 2020)

4

i10Index(all)

2

i10Index(since 2020)

2

Email

University Profile Page

Google Scholar

Maria Rita Massaro Skills & Research Interests

Marketing & Innovazione

Top articles of Maria Rita Massaro

Title

Journal

Author(s)

Publication Date

Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from …

Radiotherapy and Oncology

D Franceschini

C Franzese

T Comito

MB Ilieva

R Spoto

...

2024/6/1

The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma

Journal of Cancer Research and Clinical Oncology

Ciro Franzese

Beatrice Marini

Davide Baldaccini

Marco Badalamenti

Pierina Navarria

...

2023/7

Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review

Maria Ausilia Teriaca

Maria Massaro

Ciro Franzese

Tiziana Comito

Marta Scorsetti

2023

PO-1585 Stereotactic ablative radiotherapy (SABR) for multiple oligometastases: efficacy and safety

Radiotherapy and Oncology

C Franzese

V Vernier

D Franceschini

T Comito

P Navarria

...

2023/5/1

PD-0806 Pattern of failure after SBRT for oligometastases: predictive factors for poli-progression

Radiotherapy and Oncology

D Franceschini

V Vernier

L Cozzi

L Di Cristina

AM Marzo

...

2023/5/1

PO-1373 Stereotactic Body Radiotherapy in isolated recurrence of pancreatic cancer after radical surgery

Radiotherapy and Oncology

M Massaro

T Comito

MA Teriaca

C Franzese

L Di Cristina

...

2023/5/1

Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)

Journal of Cancer Research and Clinical Oncology

Ciro Franzese

Veronica Vernier

Davide Franceschini

Tiziana Comito

Pierina Navarria

...

2023/9

PO-1364 stereotactic radiotherapy for oligometastatic esophagogastric carcinoma outcome, prognostic factors

Radiotherapy and Oncology

L Di Cristina

D Franceschini

MA Teriaca

V Vernier

L Lo Faro

...

2023/5/1

Can STEreotactic body radiation therapy (SBRT) improve the prognosis of unresectable locally advanced pancreatic cancer? Long-term clinical outcomes, toxicity and prognostic …

Current Oncology

Tiziana Comito

Maria Massaro

Maria Ausilia Teriaca

Ciro Franzese

Davide Franceschini

...

2023/7/24

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors

The British Journal of Radiology

Davide Franceschini

Maria Ausilia Teriaca

Luciana Di Cristina

Veronica Vernier

Lorenzo Lo Faro

...

2023/4/1

Impact of stereotactic body radiation therapy on the prognosis of unresectable pancreatic cancer. Clinical results and prognostic factors on 142 patients.

Journal of Radiosurgery & SBRT

Luciana Di Cristina

Tiziana Comito

Maria Massaro

Maria Ausilia Teriaca

Beatrice Marini

...

2022/1/2

Principles of Radiotherapy

Martin Swinton

Andrew Hudson

2023/7/14

Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy

Current Oncology

Maria Massaro

Davide Franceschini

Ruggero Spoto

Luca Dominici

Ciro Franzese

...

2022/7/12

PD-0582 Phase II trial of SBRT for adrenal metastases: efficacy and impact on hormonal production.

Radiotherapy and Oncology

C Franzese

S Stefanini

M Massaro

T Comito

P Navarria

...

2022/5/1

PO-1281 Hypofractionation in locally advanced NSCLC: outcome, toxicity and predictive factors

Radiotherapy and Oncology

D Franceschini

A Marzo

L Lo Faro

B Marini

L Di Cristina

...

2022/5/1

PO-1497 Stereotactic and hypofractionated radiotherapy associated with immune checkpoints inhibitors

Radiotherapy and Oncology

D Anzellini

V De Sanctis

M Valeriani

G Vullo

G Facondo

...

2021/8/1

Stereotactic body radiation therapy boost in patients with cervical cancer ineligible for brachytherapy

Cancer Diagnosis & Prognosis

Giuseppe Facondo

Gianluca Vullo

VITALIANA DE SANCTIS

Maurizio Valeriani

Anna Maria Ascolese

...

2021/5

Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production

Journal of Cancer Research and Clinical Oncology

Ciro Franzese

Sara Stefanini

Maria Massaro

Tiziana Comito

Pierina Navarria

...

2021/12

Stereotactic and hypofractionated radiotherapy associated with immune checkpoint inhibitor drugs: analysis of local control, toxicity, and outcome in a single research centre …

Anticancer Research

Dimitri Anzellini

Vitaliana De Sanctis

Maurizio Valeriani

Chiara Reverberi

Luca Marinelli

...

2021/10/1

Androgen receptor targeted therapy+ radiotherapy in metastatic castration resistant prostate cancer

Frontiers in Oncology

Maria Massaro

Giuseppe Facondo

Gianluca Vullo

Anna Maria Aschelter

Alessandro Rossi

...

2021/9/23

See List of Professors in Maria Rita Massaro University(University of Bedfordshire)